James Parslow
2017
In 2017, James Parslow earned a total compensation of $890.8K as Chief Financial Officer at Xenetic Biosciences.
Compensation breakdown
| Option Awards | $667,216 |
|---|---|
| Salary | $198,750 |
| Other | $24,830 |
| Total | $890,796 |
Parslow received $667.2K in option awards, accounting for 75% of the total pay in 2017.
Parslow also received $198.8K in salary and $24.8K in other compensation.
Rankings
In 2017, James Parslow's compensation ranked 9,523rd out of 14,666 executives tracked by ExecPay. In other words, Parslow earned more than 35.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,523 out of 14,666 | 35th |
Division Manufacturing | 3,666 out of 5,768 | 36th |
Major group Chemicals And Allied Products | 1,265 out of 2,074 | 39th |
Industry group Drugs | 1,017 out of 1,730 | 41st |
Industry Pharmaceutical Preparations | 799 out of 1,329 | 40th |
Source: SEC filing on November 13, 2018.
Parslow's colleagues
We found three more compensation records of executives who worked with James Parslow at Xenetic Biosciences in 2017.